Violation Tracker Parent Company Summary

Parent Company Name: 
UCB
Ownership Structure: 
publicly traded
Headquartered in: 
Belgium
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$67,132,204
Number of records: 
8
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
healthcare-related offenses$34,000,0002
government-contracting-related offenses$25,350,0003
employment-related offenses$5,500,0001
competition-related offenses$2,275,4541
safety-related offenses$6,7501
Top 5 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$34,000,0002
False Claims Act and related$25,350,0003
benefit plan administrator violation$5,500,0001
price-fixing or anti-competitive practices$2,275,4541
workplace safety or health violation$6,7501
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

Schwarz Pharma Inc.; SCHWARZ PHARMA MFG; UCB; UCB Holdings, Inc.; UCB Pharma, Inc.

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Companysort icon Primary Offense Type Year Agency Penalty Amount
Schwarz Pharma Inc. False Claims Act and related 2010 DOJ_CIVIL $22,000,000
Schwarz Pharma Inc. False Claims Act and related 2010 MULTI-AG (*) $9,756,164
SCHWARZ PHARMA MANUFACTURING, INC. workplace safety or health violation 2010 OSHA $6,750
UCB False Claims Act and related 2013 LA-AG $3,350,000
UCB Holdings, Inc. benefit plan administrator violation 2017 private lawsuit-federal $5,500,000
UCB Inc. off-label or unapproved promotion of medical products 2011 FDA $34,000,000
UCB Inc. off-label or unapproved promotion of medical products 2011 MULTI-AG (*) $9,893,322
UCB Pharma, Inc. price-fixing or anti-competitive practices 2009 MULTI-AG $2,275,454
Download results as CSV or XML